BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11567943)

  • 1. Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.
    Chessells JM; Harrison G; Richards SM; Bailey CC; Hill FG; Gibson BE; Hann IM
    Arch Dis Child; 2001 Oct; 85(4):321-5. PubMed ID: 11567943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down's syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trials. Berlin-Frankfurt-Münster Group.
    Dördelmann M; Schrappe M; Reiter A; Zimmermann M; Graf N; Schott G; Lampert F; Harbott J; Niemeyer C; Ritter J; Dörffel W; Nessler G; Kühl J; Riehm H
    Leukemia; 1998 May; 12(5):645-51. PubMed ID: 9593260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI).
    Hargrave DR; Hann II; Richards SM; Hill FG; Lilleyman JS; Kinsey S; Bailey CC; Chessells JM; Mitchell C; Eden OB;
    Br J Haematol; 2001 Feb; 112(2):293-9. PubMed ID: 11167821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment related deaths during induction and in first remission in acute lymphoblastic leukaemia: MRC UKALL X.
    Wheeler K; Chessells JM; Bailey CC; Richards SM
    Arch Dis Child; 1996 Feb; 74(2):101-7. PubMed ID: 8660070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Down's syndrome with acute leukaemia.
    Levitt GA; Stiller CA; Chessells JM
    Arch Dis Child; 1990 Feb; 65(2):212-6. PubMed ID: 2138446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down syndrome and acute lymphoblastic leukaemia.
    Whitlock JA
    Br J Haematol; 2006 Dec; 135(5):595-602. PubMed ID: 17054672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term prognosis of children with Down's syndrome and leukaemia: a 34-year nation-wide experience.
    Rajantie J; Siimes MA
    J Intellect Disabil Res; 2003 Nov; 47(Pt 8):617-21. PubMed ID: 14641809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
    Arico M; Ziino O; Valsecchi MG; Cazzaniga G; Baronci C; Messina C; Pession A; Santoro N; Basso G; Conter V;
    Cancer; 2008 Aug; 113(3):515-21. PubMed ID: 18521927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI.
    Chessells JM; Harrison G; Richards SM; Gibson BE; Bailey CC; Hill FG; Hann IM;
    Br J Haematol; 2002 Aug; 118(2):445-55. PubMed ID: 12139731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
    Chessels JM; Swansbury GJ; Reeves B; Bailey CC; Richards SM
    Br J Haematol; 1997 Oct; 99(1):93-100. PubMed ID: 9359508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and treatment outcome of children with acute lymphocytic leukemia and Down's syndrome. A Pediatric Oncology Group study.
    Ragab AH; Abdel-Mageed A; Shuster JJ; Frankel LS; Pullen J; van Eys J; Sullivan MP; Boyett J; Borowitz M; Crist WM
    Cancer; 1991 Feb; 67(4):1057-63. PubMed ID: 1825025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study group.
    Buitenkamp TD; Izraeli S; Zimmermann M; Forestier E; Heerema NA; van den Heuvel-Eibrink MM; Pieters R; Korbijn CM; Silverman LB; Schmiegelow K; Liang DC; Horibe K; Arico M; Biondi A; Basso G; Rabin KR; Schrappe M; Cario G; Mann G; Morak M; Panzer-Grümayer R; Mondelaers V; Lammens T; Cavé H; Stark B; Ganmore I; Moorman AV; Vora A; Hunger SP; Pui CH; Mullighan CG; Manabe A; Escherich G; Kowalczyk JR; Whitlock JA; Zwaan CM
    Blood; 2014 Jan; 123(1):70-7. PubMed ID: 24222333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of treatment for relapsed acute lymphoblastic leukaemia in children with Down syndrome.
    Meyr F; Escherich G; Mann G; Klingebiel T; Kulozik A; Rossig C; Schrappe M; Henze G; von Stackelberg A; Hitzler J
    Br J Haematol; 2013 Jul; 162(1):98-106. PubMed ID: 23594030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97/99 and UKALL2003 clinical trials.
    Enshaei A; Vora A; Harrison CJ; Moppett J; Moorman AV
    Lancet Haematol; 2021 Nov; 8(11):e828-e839. PubMed ID: 34715050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of acute lymphoblastic leukemia in children with down syndrome-Polish pediatric leukemia and lymphoma study group report.
    Zawitkowska J; Odój T; Drabko K; Zaucha-Prażmo A; Rudnicka J; Romiszewski M; Matysiak M; Kwiecińska K; Ćwiklińska M; Balwierz W; Owoc-Lempach J; Derwich K; Wachowiak J; Niedźwiecki M; Adamkiewicz-Drożyńska E; Trelińska J; Młynarski W; Kołtan A; Wysocki M; Tomaszewska R; Szczepański T; Płonowski M; Krawczuk-Rybak M; Ociepa T; Urasiński T; Mizia-Malarz A; Sobol-Milejska G; Karolczyk G; Kowalczyk J
    Pediatr Hematol Oncol; 2017 May; 34(4):199-205. PubMed ID: 29040012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
    Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
    Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia in children with Down syndrome: Comparative analysis versus patients without Down syndrome.
    Pennella CL; Rossi JG; Baialardo EM; Alonso CN; Guitter MR; Sánchez La Rosa CG; Millán NC; Alfaro EM; Zubizarreta PA; Felice MS
    Arch Argent Pediatr; 2018 Aug; 116(4):e500-e507. PubMed ID: 30016023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.
    Bercovich D; Ganmore I; Scott LM; Wainreb G; Birger Y; Elimelech A; Shochat C; Cazzaniga G; Biondi A; Basso G; Cario G; Schrappe M; Stanulla M; Strehl S; Haas OA; Mann G; Binder V; Borkhardt A; Kempski H; Trka J; Bielorei B; Avigad S; Stark B; Smith O; Dastugue N; Bourquin JP; Tal NB; Green AR; Izraeli S
    Lancet; 2008 Oct; 372(9648):1484-92. PubMed ID: 18805579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome and toxicity of chemotherapy for acute lymphoblastic leukemia in children with Down syndrome.
    Shah N; Al-Ahmari A; Al-Yamani A; Dupuis L; Stephens D; Hitzler J
    Pediatr Blood Cancer; 2009 Jan; 52(1):14-9. PubMed ID: 18802938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
    Chessells JM; Richards SM; Bailey CC; Lilleyman JS; Eden OB
    Br J Haematol; 1995 Feb; 89(2):364-72. PubMed ID: 7873387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.